626
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Accelerator mass spectrometry detection of beryllium ions in the antigen processing and presentation pathway

, , , &
Pages 181-187 | Received 26 Feb 2014, Accepted 21 Apr 2014, Published online: 16 Jun 2014

References

  • Amicosante, M., Berretta, F., Rossman, M., et al. 2005. Identification of HLA-DRPheβ47 as the susceptibility marker of hyper-sensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGluβ69. Respir. Res. 6:94
  • Chiarappa-Zucca, M. L., Finkel, R. C., Martinelli, R. E., et al. 2004. Measurement of beryllium in biological samples by accelerator mass spectrometry: Applications for studying Chronic Beryllium Disease. Chem. Res. Toxicol. 17:1614–1620
  • Finkel, R. C., and Nishiizumi, K. 1997. Beryllium-10 concentrations in the Greenland Ice Sheet Project 2 ice core from 3–40 ka. J. Geophys. Res. 102:26669–26706
  • Fontenot, A. P., Canavera, S. J., Gharavi, L., et al. 2002. Target organ localization of memory CD4+ T-cells in patients with Chronic Beryllium Disease. J. Clin. Invest. 110:1473–1482
  • Fontenot, A. P., Keizer, T. S., McCleskey, M., et al. 2006. Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T-cells. J. Immunol. 177:3874–3883
  • Fontenot, A. P., Newman, L. S., and Kotzin, B. L. 2001. Chronic Beryllium Disease: T-cell recognition of a metal presented by HLA-DP. Clin. Immunol. 100:4–14
  • Fontenot, A. P., Palmer, B. E., Sullivan, A. K., et al. 2005. Frequency of beryllium-specific, central memory CD4+ T-cells in blood determines proliferative response. J. Clin. Invest. 115:2886–2893
  • Fontenot, A. P., Torres, M., Marshall, W. H., et al. 2000. Beryllium presentation to CD4+ T-cells underlies disease-susceptibility HLA-DP alleles in Chronic Beryllium Disease. Proc. Natl. Acad. Sci. USA 97:12717–12722
  • Henneberger, P. K., Goe, S. K., Miller, W. E., et al. 2004. Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed. J. Occup. Environ. Hyg. 1:648–659
  • Infante, P. F., and Newman, L. S. 2004. Beryllium exposure and Chronic Beryllium Disease. Lancet 363:415–416
  • Lu, L., Vollmer, J., Moulon, C., et al. 2003. Components of the ligand for a Ni++ reactive human T-cell clone. J. Exp. Med. 197:567–574
  • Newman, L. S., Mroz, M. M., Balkissoon, R., and Maier, L. A. 2005. Beryllium sensitization progresses to Chronic Beryllium Disease: A longitudinal study of disease risk. Am. J. Respir. Crit. Care Med. 171:54–60
  • Newman, L. S., Rose, C. S., Bresnitz, E. A., et al. 2004. A case control etiologic study of sarcoidosis: Environmental and occupational risk factors. Am. J. Respir. Crit. Care Med. 170:1324–1330
  • Pott, G. B., Palmer, B. E., Sullivan, A. K., et al. 2005. Frequency of beryllium-specific, TH1-type cytokine-expressing CD4+ T-cells in patients with beryllium-induced disease. J. Allergy Clin. Immunol. 115:1036–1042
  • Price, D. J., and Joshi, J. G. 1983. Ferritin. Binding of beryllium and other divalent metal ions. J. Biol. Chem. 258:10873–10880
  • Rossman, M. D., Kern, J. A., Elias, J. A., et al. 1988. Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for Chronic Beryllium Disease. Ann. Int. Med. 108:687–693
  • Saltini, C., Kirby, M., Trapnell, B. C., et al. 1990. Biased accumulation of T-lymphocytes with “memory”-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J. Exp. Med. 171:1123–1140
  • Saltini, C., Winestock, K., Kirby, M., et al. 1989. Maintenance of alveolitis in patients with Chronic Beryllium Disease by beryllium-specific helper T-cells. New Engl. J. Med. 320:1103–1109
  • Sawyer, R. T., Day, B. J., Fadok, V. A., et al. 2004a. Beryllium-ferritin: Lymphocyte proliferation and macrophage apoptosis in Chronic Beryllium Disease. Am. J. Respir. Cell. Mol. Biol. 169:893–895
  • Sawyer, R. T., Parsons, C. E., Fontenot, A. P., et al. 2004b. Beryllium-induced TNFα production by CD4+ T-cells is mediated by HLA-DP. Am. J. Respir. Cell. Mol. Biol. 31:122–130
  • Stephan, C. H., Fournier, M., Brousseau, P., and Sauve, S. 2008. Graphite furnace atomic absorption spectrometry as routine method for the quantification of Be in blood and serum. Chem. Cent. J. 2:14
  • Tinkle, S. S., Kittle, L. A., Schumacher, B. A., and Newman, L. S. 1997. Beryllium induces IL-2 and IFNγ in berylliosis. J. Immunol. 158:518–526

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.